Clinical Trials
2 trialsNCT01931592 2017-05-08
CLEAR
University of Cologne
Phase 2/3 Terminated
NCT01523431 2017-03-30
Individual Dosage Selection of Irinotecan (CPT-11) Based on UGT1A1 Genotype in Metastatic Colorectal Cancer Patients
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences
Phase 2/3 Completed